Getting the Information You Need
At Siskinds, each of our lawyers focuses on a specific area of law. We can provide you with the information, facts or quotes you need to help you cover virtually any topic related to the law. At times, interviews can be arranged at short-notice as we understand that your timelines can be immediate and firm.
The quickest way to reach the right lawyer for your story, is to contact one of the marketing team members listed below. To view previous media appearances of our lawyers and our firm, also listed below are recent instances in which we’ve been in the news, participated in a speaking engagement, or issued a media release.
Class Actions Listing
Filter By:Reset Filters
Business and privacy law lawyer, Michael Weinberger, was interviewed by Christine Van Geyn from Canadian Justice on legal and ethical issues surrounding multi-level marketing. Michael discusses the type of industries and businesses that multi-level marketing works best for, how to tell the difference between legitimate multi-level marketing companies and pyramid schemes, and more. Watch the...
Siskinds personal injury lawyers Rasha El-Tawil and Maciek Piekosz will be presenting at the Ontario Trial Lawyers Association 2021 conference in October. About the event: A full day of educational presentations and panel discussions from experienced legal colleagues & the bench to provide you with the knowledge, skills, tips and tricks to further your legal...
Siskinds personal injury lawyer, Rasha El-Tawil, will be participating as a panelist in a panel discussion at the Canadian Muslim Lawyers Association (CMLA) National Legal Conference on the topic of pathways to leadership. Date: September 25-26, 2021Cost: FREE for CMLA members, $80 for non-members and $25 for students Learn more
MONTREAL, Sept. 14, 2021 /CNW/ – A Canada-wide settlement agreement was recently reached in a class action related to the use of Depo-Provera, an injectable form of birth control, and bone mineral density loss. In the class action, which was authorized on May 28, 2008, the representative plaintiff alleges that Pfizer misrepresented the risks associated with the use of...